Emerging role of sertindole in the management of schizophrenia

Código QR

Emerging role of sertindole in the management of schizophrenia

Stephanie L Cincotta1, Joshua S Rodefer21Georgetown University School of Medicine, Washington DC, USA; 2Department of Psychology and Program in Neuroscience, Florida State University, Tallahassee, Florida, USAAbstract: The atypical antipsychotic sertindole is a phenylindole-derived compound that has...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Stephanie L Cincotta, Joshua S Rodefer
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2010
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/54a61a278221476bac4276dd15dce0b8
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

The role of family therapy in the management of schizophrenia: challenges and solutions
por: Caqueo-Urízar A, et al.
Publicado: (2015)

Critical appraisal of lurasidone in the management of schizophrenia
por: Caccia S, et al.
Publicado: (2012)

Role of aripiprazole in treatment-resistant schizophrenia
por: Mossaheb N, et al.
Publicado: (2012)

Role of sublingual asenapine in treatment of schizophrenia
por: Citrome L
Publicado: (2011)

Update on the management of symptoms in schizophrenia: focus on amisulpride
por: Ann M Mortimer
Publicado: (2009)

Clinical utility of the risperidone formulations in the management of schizophrenia
por: Madaan V, et al.
Publicado: (2011)

The management of schizophrenia: focus on extended-release quetiapine fumarate
por: Peuskens J
Publicado: (2011)

Differential diagnoses and management strategies in patients with schizophrenia and bipolar disorder
por: A Carlo Altamura, et al.
Publicado: (2008)

Soccer practice as an add-on treatment in the management of individuals with a diagnosis of schizophrenia
por: Battaglia G, et al.
Publicado: (2013)

Strategies to improve medication adherence in patients with schizophrenia: the role of support services
por: El-Mallakh P, et al.
Publicado: (2015)

Use of second-generation antipsychotics in the acute inpatient management of schizophrenia in the Middle East
por: Alkhadhari S, et al.
Publicado: (2015)

Current and emerging treatment options in the management of Friedreich ataxia
por: Michelangelo Mancuso, et al.
Publicado: (2010)

The cost of schizophrenia in Japan
por: Sado M, et al.
Publicado: (2013)

Jumping to conclusions in schizophrenia
por: Evans SL, et al.
Publicado: (2015)

Aripiprazole for the management of schizophrenia in the Japanese population: a systematic review and meta-analysis of randomized controlled trials
por: Kishi T, et al.
Publicado: (2015)

Comparing the influences of age and disease on the Brief Assessment of Cognition in Schizophrenia in Japanese patients with schizophrenia
por: Kaneda A, et al.
Publicado: (2013)

Pharmacotherapy for treatment-resistant schizophrenia
por: Meghan E Mcilwain, et al.
Publicado: (2011)

Profile of blonanserin for the treatment of schizophrenia
por: Tenjin T, et al.
Publicado: (2013)

Psychosurgery for schizophrenia: history and perspectives
por: Soares MS, et al.
Publicado: (2013)

The emerging role of bexarotene in the treatment of Alzheimer’s disease: current evidence
por: Tousi B
Publicado: (2015)

Optimal management of seizures associated with tuberous sclerosis complex: current and emerging options
por: Wang S, et al.
Publicado: (2014)

Influence of 5-HT1A and 5-HTTLPR genetic variants on the schizophrenia symptoms and occurrence of treatment-resistant schizophrenia
por: Terzić T, et al.
Publicado: (2015)

Once-monthly paliperidone injection for the treatment of schizophrenia
por: Delia Bishara
Publicado: (2010)

Profile of minocycline and its potential in the treatment of schizophrenia
por: Zhang L, et al.
Publicado: (2014)

The relationship between insight and subjective experience in schizophrenia
por: Kako Y, et al.
Publicado: (2014)

Towards a framework for treatment effectiveness in schizophrenia
por: Juckel G, et al.
Publicado: (2014)

Atypical antipsychotics in the treatment of early-onset schizophrenia
por: Hrdlicka M, et al.
Publicado: (2015)

Augmentation with antidepressants in schizophrenia treatment: benefit or risk
por: Mao YM, et al.
Publicado: (2015)

The clinical utility of lurasidone in schizophrenia: patient considerations
por: Harvey PD
Publicado: (2015)

Aripiprazole-associated tic in a schizophrenia patient
por: Guo X, et al.
Publicado: (2015)

Predictors of quality of life among individuals with schizophrenia
por: Suttajit S, et al.
Publicado: (2015)

Role and rationale for the use of milnacipran in the management of fibromyalgia
por: Jay D Kranzler, et al.
Publicado: (2010)

Role of oral teriflunomide in the management of multiple sclerosis
por: Tanasescu R, et al.
Publicado: (2013)

Emerging treatments in the management of bipolar disorder &ndash; focus on risperidone long acting injection
por: Wissam El-Hage, et al.
Publicado: (2010)

Early prediction of blonanserin response in Japanese patients with schizophrenia
por: Kishi T, et al.
Publicado: (2014)

Reduced reward-related probability learning in schizophrenia patients
por: Yılmaz A, et al.
Publicado: (2012)

Semantics, pragmatics, and formal thought disorders in people with schizophrenia
por: Salavera C, et al.
Publicado: (2013)

Stimulus-dependent effects on right ear advantage in schizophrenia
por: Smucny J, et al.
Publicado: (2012)

Dietary patterns and schizophrenia: a comparison with healthy controls
por: Tsuruga K, et al.
Publicado: (2015)

Yokukansan and its ingredients as possible treatment options for schizophrenia
por: Yu CH, et al.
Publicado: (2014)